 The main objective is to develop pharmacokinetic methods for individual dose adjustment of the global immunosuppressive treatment cyclosporine, tacrolimus, mycophenolate mofetil and everolimus, taking into account the pharmacokinetic interactions, in order to optimise the efficiency and reduce the potentially severe sides effects of these drugs. 